Liebenberg LJ, Masson L, Arnold KB, McKinnon LR, Werner L, Proctor E, Archary D, Mansoor LE, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore Jo-AS.
J Acquir Immune Defic Syndr 2017; 74(3):318-325.
Daftary A, Hirsch-Moverman Y, Kassie GM, Melaku Z, Gadisa T, Saito S, Howard AA.
AIDS and Behavior 2017: doi:10.1007/s10461-016-1432-8.
Upfold M, Grobler A, Suleman F, Mansoor LE.
AIDS and Behavior 2017; 21(2):462-469.
de Oliveira T, Kharsany ABM, Gräf T, Cawood C, Khanyile D, Grobler A, Puren A, Madurai S, Baxter C, Abdool Karim Q, Abdool Karim SS.
Lancet HIV 2017; 4(1):e41-e50.
Doria-Rose NA, Altae-Tran HR, Roark RS, Schmidt SD, Sutton MS, Louder MK, Chuang GY, Bailer RT, Cortez V, Kong R, McKee K, O'Dell S, Wang F, Abdool Karim SS, Binley JM, Connors M, Haynes BF, Martin MA, Montefiori DC, Morris L, Overbaugh J, Kwong PD, Mascola JR, Georgiev IS.
PLoS Pathogens 2017; 13(1):e1006148.
Thobakgale C, Naidoo K, McKinnon LR, Werner L, Samsunder N, Abdool Karim SS, Ndung'u T, Altfeld M, Naidoo K.
J Acquir Immune Defic Syndr. 2017; 74(2):213-220.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.